AR047967A1 - Derivados de pirimidina utiles para tratar enfermedades de reflujo gastro-esofagico. - Google Patents

Derivados de pirimidina utiles para tratar enfermedades de reflujo gastro-esofagico.

Info

Publication number
AR047967A1
AR047967A1 ARP050100614A ARP050100614A AR047967A1 AR 047967 A1 AR047967 A1 AR 047967A1 AR P050100614 A ARP050100614 A AR P050100614A AR P050100614 A ARP050100614 A AR P050100614A AR 047967 A1 AR047967 A1 AR 047967A1
Authority
AR
Argentina
Prior art keywords
diseases
derivatives useful
esofagic
reflection
halogen
Prior art date
Application number
ARP050100614A
Other languages
English (en)
Original Assignee
Nps Pharma Inc
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nps Pharma Inc, Astrazeneca Ab filed Critical Nps Pharma Inc
Publication of AR047967A1 publication Critical patent/AR047967A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Derivados de pirimidina utiles para tratar enfermedades de reflujo gastro-esofágico, proceso para su preparacion, su uso en terapia y composiciones farmacéuticas que comprenden dichos compuestos. Reivindicacion 1: Un compuesto de formula (1) caracterizado porque R1, R2, R3 y R4 se seleccionan cada uno y en forma independientemente entre H, alquilo C1-4, halogeno, CN y NO2; R5 y R6 se seleccionan cada uno y en forma independiente entre hora, halogeno, CN y NO2; Q es arilo o heteroarilo, opcionalmente sustituido por H, alquilo C1-4, alquenilo C2-4, halogeno, alcoxi, CH2F, CHF2, CF3, NH2, NHAc., OH, OAc o ésteres carboxílicos y donde uno o más de los sustituyentes puede formar parte de un anillo; así como sales, hidratos, isoformas y/o isomeros opticos de los mismos aceptables para uso farmacéutico.
ARP050100614A 2004-02-20 2005-02-18 Derivados de pirimidina utiles para tratar enfermedades de reflujo gastro-esofagico. AR047967A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54590504P 2004-02-20 2004-02-20

Publications (1)

Publication Number Publication Date
AR047967A1 true AR047967A1 (es) 2006-03-15

Family

ID=34910738

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050100614A AR047967A1 (es) 2004-02-20 2005-02-18 Derivados de pirimidina utiles para tratar enfermedades de reflujo gastro-esofagico.

Country Status (4)

Country Link
AR (1) AR047967A1 (es)
TW (1) TW200538180A (es)
UY (1) UY28762A1 (es)
WO (1) WO2005082884A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101415681A (zh) * 2006-03-29 2009-04-22 弗·哈夫曼-拉罗切有限公司 作为mGluR2拮抗剂的吡啶和嘧啶衍生物
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
JP2013518085A (ja) 2010-02-01 2013-05-20 ノバルティス アーゲー ＣＲＦ−１受容体アンタゴニストとしてのピラゾロ［５，１ｂ］オキサゾール誘導体
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
JP5748777B2 (ja) 2010-02-02 2015-07-15 ノバルティス アーゲー Ｃｒｆ受容体アンタゴニストとしてのシクロヘキシルアミド誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3922735A1 (de) * 1989-07-11 1991-01-24 Hoechst Ag Aminopyrimidin-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als fungizide
DE4029649A1 (de) * 1990-09-19 1992-03-26 Hoechst Ag Alkoxypyridyl-pyrimidin-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als fungizide
US20020152479A1 (en) * 2000-01-13 2002-10-17 Lehmann Jurgen M. Car modulators: screening and treatment of hypercholesterolemia

Also Published As

Publication number Publication date
WO2005082884A3 (en) 2006-05-18
TW200538180A (en) 2005-12-01
UY28762A1 (es) 2005-08-31
WO2005082884A2 (en) 2005-09-09

Similar Documents

Publication Publication Date Title
AR054799A1 (es) Derivados de oxindol
ES2528451T3 (es) Inhibidores de esfingosina cinasa
AR063022A1 (es) Derivados de indol antagonistas del receptor de glucagon, composiciones farmaceuticas que los contienen y usos para tratar diabetes mellitus tipo 2 y estados patologicos relacionados.
PE20121509A1 (es) Compuestos de triazolopiridinas como inhibidores de quinasa mps-1
AR051735A1 (es) Inhibidores pirrolicos de la proteina quinasa erk, sintesis e intermediarios de los mismos.
BRPI0608732A2 (pt) composto ou um sal, hidrato, solvato, complexo ou pró-droga farmaceuticamente aceitável do mesmo, sal de um composto, processo para a preparação de um composto, uso de um composto, composição farmacêutica, e, produto
PE20050691A1 (es) Proceso para preparar carboxamidas 2-aminotiazol-5-aromaticas como inhibidores de la cinasa
RS54070B1 (en) SUBSTITUTED N- (1H-INDASOL-4-IL) IMIDASO [1,2-a] PIRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYROSINE KINASE TYPE III RECIPE INHIBITORS
PE20110285A1 (es) Derivados de sulfonamidofenil propionamida como ligandos del receptor vaniloide del subtipo 1
PE20020354A1 (es) Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
AR066043A1 (es) Derivados de benzamida sustituida como inhibidores de la 11-beta-hidroxi esteroide deshidrogenasa tipo 1(11betahsd1)
PE20141075A1 (es) 4-aril-n-fenil-1,3,5-triazin-2-aminas que contienen un grupo sulfoximina
PE20130149A1 (es) Derivados de la cromenona con actividad anti-tumoral
UY30323A1 (es) Uso de bifenilamidas de acido arilcarboxilico para el tratamiento de semillas
PE20081888A1 (es) ANALOGOS DE PIRAZOLOPIRIMIDINA Y SU USO COMO INHIBIDORES DE CINASA mTOR Y CINASA PI3
AR065499A1 (es) Inhibidores de serino proteasas.composiciones farmaceuticas
ES2314418T3 (es) Derivados de amidas del acido 4-bromo-5-(2-clorobenzoilamino)-1h-pirazol-3-carboxicilico y compuestos relacionados como antagonistas del receptor b1 de bradiquinina para el tratamiento de enfermedades inflamatorias.
AR058077A1 (es) Derivados de acidos fenoxiaceticos
PE20141598A1 (es) Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina
DK1755606T4 (da) Quinazolinonderivater, der er anvendelige som vanilloid-antagonister
AR051795A1 (es) Derivados de hidantoina inhibidores de metaloproteinasas
AR048834A1 (es) Compuestos derivados de piperidina o tropano; metodos para su preparacion; composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades mediadas por quimioquinas (ccr5)
AR054508A1 (es) Compuesto de bencilpiperazina, su uso para preparar un medicamento, procedimientos para la preparacion de dicho compuesto y de compuestos intermediarios, dichos compuestos intermediarios, composicion farmaceutica que lo comprende y procedimiento para prepararla
AR051796A1 (es) Derivados de hidantoina como inhibidores de metaloproteinasas
AR047967A1 (es) Derivados de pirimidina utiles para tratar enfermedades de reflujo gastro-esofagico.

Legal Events

Date Code Title Description
FB Suspension of granting procedure